Sentences with phrase «ovarian cancer as»

The testimony was part of a lawsuit filed by a South Dakota woman in 2006, which ruled that Johnson & Johnson was negligent about the dangers of its product but awarded no damages to the woman, who did develop ovarian cancer as the result of her talcum powder use.

Vets at Integrative Pet Care will be able to assist clients with information on symptoms of ovarian cancer as well as on finding more information and, if necessary, medical assistance.

Rosenthal was fighting ovarian cancer as she composed the column, titled You May Want to Marry My Husband, for the New York Times.

The final chapter provides contemporary guidelines for the initial management of ovarian cancer as well as for recurrent disease.

Most of these therapies are still in early - phase testing (phase I and II) for ovarian cancer, but their successful use in other types of cancers suggests that they may ultimately prove useful for ovarian cancer as well.

Breastfeeding is believed to lower the risks of ovarian cancer as well.

The longer a woman breastfeeds, the greater she can reduce her risk of breast and ovarian cancer as well as diabetes.

Not exact matches

Shares of Clovis Oncology closed up 8.82 percent Monday as the company received early approval for its advanced ovarian cancer drug Rubraca (rucaparib).

The products are being studied as treatments for skin cancer, recurrent ovarian cancer and high LDL, or bad cholesterol, that doesn't respond to pills such as Lipitor.

Most women don't understand that the incidence of endocrine disruptive disorders such as endometriosis, fibroids, polycystic ovarian syndrome, infertility, early onset puberty, early onset menopause, heavy, painful and prolonged periods and breast cancer are mainly caused by the endocrine disruptive chemicals found in skin, hair, beauty and personal products.

Yet 20 % of women diagnosed with lung cancer each year — about 21,000 in 2010, roughly the same number as new cases of ovarian cancer — never smoked.

Studies show that the longer a woman breastfeeds the more she reduces the risk of many illnesses to her child (such as childhood cancers) and risk of illness to herself (lower risk of breast, ovarian, and cervical cancer).

As well as bonding with the baby when sharing the breastfeeding, lesbian parents report enjoying the effects of the relaxation hormones released when lactating (resulting in lower stress levels in the parent and baby), the flexibility of having two nursing parents when one needs to absent herself occasionally or when returning to work, and the health benefits of breastfeeding such as lower rates of breast cancer, ovarian cancer and Type II diabetes (8), (9As well as bonding with the baby when sharing the breastfeeding, lesbian parents report enjoying the effects of the relaxation hormones released when lactating (resulting in lower stress levels in the parent and baby), the flexibility of having two nursing parents when one needs to absent herself occasionally or when returning to work, and the health benefits of breastfeeding such as lower rates of breast cancer, ovarian cancer and Type II diabetes (8), (9as bonding with the baby when sharing the breastfeeding, lesbian parents report enjoying the effects of the relaxation hormones released when lactating (resulting in lower stress levels in the parent and baby), the flexibility of having two nursing parents when one needs to absent herself occasionally or when returning to work, and the health benefits of breastfeeding such as lower rates of breast cancer, ovarian cancer and Type II diabetes (8), (9as lower rates of breast cancer, ovarian cancer and Type II diabetes (8), (9).

For mothers, breastfeeding has been correlated with a significant decrease in the risk of diseases such as breast cancer, ovarian cancer, diabetes, and heart disease to name just a few.

Breastfeeding can also reduce the chances for some women of getting diseases such as breast or ovarian cancer later in life.

• Breastmilk protects babies from illness and can also reduce the risk of Type 1 diabetes, childhood leukemia and other serious illnesses, as well as lowering the risk of sudden infant death syndrome (SIDS); • Breastfeeding is healthy for moms, including lowering their risk of Type 2 diabetes, breast cancer, ovarian cancer and postpartum depression; • Breastfeeding saves families money on the cost of formula and illness; and • Breastfeeding saves insurers and employers (including the military) money on the expenses of medical care and lost workplace productivity (both due to infant illness).

Benefits to mom include faster healing after delivery, lower risk for postpartum depression, as well as decreased lifetime risks for diabetes, cardiovascular disease, rheumatoid arthritis, hypertension, and breast and ovarian cancer.

Reams of research have linked breastfeeding to scores of benefits for both mom and baby: breast - fed babies aren't as likely to fall prey to obesity, ear infections or diabetes; breast - feeding moms benefit from a decreased risk of breast and ovarian cancer.

They are also at greater risk for rare but serious conditions such as severe lower respiratory infections, leukemia, necrotizing enterocolitis, and sudden infant death syndrome (SIDS).5 Breastfeeding is also good for moms, lowering the risk for breast cancer, ovarian cancer, type 2 diabetes, and cardiovascular disease.6, 7

Breastfeeding results in reduced incidence of common infections such as diarrhea, otitis media and pneumonia.5 It is associated with a reduced incidence of childhood - onset diabetes, celiac disease, Crohn's disease and some childhood malignancies.6 More recent work suggests that breastfed infants are less obese in infancy and later childhood.7 Mothers who breastfeed have a more physiologic postpartum recovery and a lower incidence of breast and ovarian cancer, osteoporosis and obesity.8

Today I would add that breastfeeding reduces ovarian and cervical cancer, juvenile rheumatoid arthritis, bacterial and viral infections of all types and increases visual acuity, optimal neurological and social and oral development, as well as saves money for health care providers and families.

• Breastmilk contains special antibodies which help protect your baby against infections • Breastmilk is your baby's natural food, it's easily digested and enough on its own for the first 6 months • Breastfed babies are less likely to have eczema and diabetes or high blood pressure and obesity later on • Breastfeeding helps you and your baby to get to know each other • Breastfeeding means you'll return to your pre-pregnancy weight quicker • Breastfeeding helps give you stronger bones in later life and helps protect against breast and ovarian cancer • Breastfed babies are not as windy as bottle - fed babies • Nappies are not as smelly!

Breastfeeding for over a year can help reduce the mother's risk of certain types of cancers such as ovarian and breast cancer.

Its consumption can worsen the condition of certain autoimmune diseases such as lupus and multiple sclerosis, breast cancer, ovarian cancer and other uterine problems.

Benefits of extended breastfeeding for mom include reduced risks of breast cancer, ovarian cancer, high blood pressure, heart disease, diabetes, and rheumatoid arthritis, as well as improved health.

A family or personal history of ovarian cancer, breast cancer or colorectal cancer increase a woman's risk as well.

lower risk of ovarian cancer, as does having used birth control at any point in your life.

It may reduce the risk of certain cancers, such as breast and ovarian And economically speaking, it's impossible to beat the price.

Full - term breast feedings further reduces the mother's risk developing breast ovarian and uterine cancers as well as reducing the risk of osteoporosis later in life.

My mom just passed away from ovarian cancer and she used talcum powder as a way of keeping her genital area dry as I was growing up.

Amy Paulin, an Assemblywoman from Westchester, is sponsoring a bill to allow what's become known as Aid in Dying, after the wrenching experience of her sister's battle with stage four ovarian cancer.

«Nonetheless, the proof of concept studies we have obtained thus far are extremely encouraging, and we are confident that with proper support and efforts we could translate our findings into experimental therapeutics for a variety of solid tumors that are driven by EphA2 overexpression, including breast, lung, prostate, pancreatic, and ovarian cancers,» said Pellecchia, who serves as the founding director of the Center for Molecular and Translational Medicine at UCR.

Wong and his lab want to see if edelfosine could be incorporated into future clinical research focused on other tumor sites such as lung, ovarian and pancreatic cancers.

Few scientific endeavors captured as much public interest as the race to identify BRCA1, a gene responsible for inherited predisposition to breast and ovarian cancers.

This change, known as somatic copy - number alterations, may be key to disease progression and might offer new therapeutic approaches for ovarian cancer and other malignancies.

«This finding,» Villanueva said «opens the door to developing new biomarkers and new therapeutic strategies exploiting these characteristics of exosomes in breast tumors, and other tumors such as ovarian and endometrial cancer among others.»

But it assesses only three of the more than 1,000 known BRCA1 / 2 mutations, raising concerns that women who are told they do not have any of those variants will be lulled into believing that, as a result, they do not have an elevated risk for breast and ovarian cancer.

«Our findings suggest that this new drug combination would also help patients with this type of aggressive breast cancer as well as other cancers, such as lung, prostate and ovarian cancers,» Dr. Rassool says.

The study published in Cancer Cell shows that exosomes from tumor cells of breast cancer (and other tumor types such as ovarian and endometrial) are different in size and composition than those of healthy Cancer Cell shows that exosomes from tumor cells of breast cancer (and other tumor types such as ovarian and endometrial) are different in size and composition than those of healthy cancer (and other tumor types such as ovarian and endometrial) are different in size and composition than those of healthy cells.

Ovarian cancer is relatively rare, ranking as the eighth-most frequent cancer, but it is the fifth - leading cause of cancer deaths among U.S. women.

For ovarian cancer, the group found a 16 % risk, compared with previous estimates that ran as high as 64 %.

Drugs known as PARP inhibitors have already been approved for BRCA - positive ovarian cancer, suggesting that PARP inhibitors may prove effective in prostate cancers with this type of aberration.

Immune therapy for ovarian, breast and colorectal cancer — treatments that encourage the immune system to attack cancer cells as the foreign invaders they are — has so far had limited success, primarily because the immune system often can't destroy the cancer cells.

A study involving Ottawa and Taiwan researchers, published in the journal Proceedings of the National Academy of Sciences (PNAS), provides new insight into why ovarian cancer is often resistant to chemotherapy, as well as a potential way to improve its diagnosis and treatment.

TRINOVA - 2 is evaluating pegylated liposomal doxorubicin in combination with either placebo or trebananib in previously treated patients with ovarian cancer while TRINOVA - 3, also known as ENGOT - Ov2 and Gynecologic Oncology Group — 3001, is studying the use of trebananib in front - line treatment adding it to carboplatin / paclitaxel.

Spontaneous immune responses were assessed by measuring serum antibodies against ovarian cancer - associated antigens, such as NY - ESO - 1, that are not expressed in normal body tissues but are expressed in cancers.

«We know that patients with BRCA mutations are at high risk for developing breast, as well as pancreatic, ovarian, prostate and other cancers, and we have learned over time that BRCA plays a very important role in DNA damage repair.

The discovery sheds new light on our understanding of the genetic complexity underpinning variations in human pigmentation, and could advance our knowledge of conditions linked to pigmentation, such as skin, testicular, prostate and ovarian cancers.

Heeke says the study would be open to people whose tumors have evidence of HRD like those found in this study, which includes bladder, breast, cervix, liver and bile duct, colorectal, endometrial, gastric / esophageal, head & neck, kidney, neuroendocrine, lung, ovarian, pancreas, prostate, sarcoma, and thyroid cancers, as well as gastrointestinal stromal tumors, glioma, melanoma and unknown primary cancers.

BRCA1 and 2, genes whose proteins are supposed to work as tumor suppressors and also repair DNA damage, were the first known risk factor genes for familial breast cancer as well as ovarian and other cancers.